Condition 101 About Amyotonia Congenita

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Top Global Doctors For Amyotonia Congenita

JD
Elite
Jean-francois Desaphy
Bari, IT
SP
Elite
Simona Portaro
Messina, IT
PI
Elite
Paola Imbrici
Bari, IT
FH
Elite
Frank Horn-Lehmann
Ulm, BW, DE
EM
Elite
Emma L. Matthews
London, ENG, GB
KR
Elite
Karin Rott-Jurkat
Albert, BW, DE
View All Doctors

Latest Advances On Amyotonia Congenita

  • Condition: Spondyloepiphyseal Dysplasia Congenita
  • Journal: Journal of pediatric orthopedics
  • Treatment Used: Valgus Hip Osteotomy
  • Number of Patients: 79
  • Published —
This study tested the safety and efficacy of using a valgus hip osteotomy to treat children aged mean 9.6 years with spondyloepiphyseal dysplasia congenita.
  • Condition: Spondyloepiphyseal Dysplasia
  • Journal: The Journal of arthroplasty
  • Treatment Used: Total Hip Arthroplasty
  • Number of Patients: 43917
  • Published —
This study tested the safety and efficacy of using total hip arthroplasty to treat patients with spondyloepiphyseal dysplasia.
View All Latest Advances

Clinical Trials For Amyotonia Congenita

Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Drug
  • Participants: 14
  • Start Date: September 1, 2021
Open-label Extension Study to Evaluate the Long-term Safety and Efficacy of Mexiletine in Paediatric Patients With Myotonic Disorders Who Have Completed the MEX-NM-301 Study.
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 14
  • Start Date: July 31, 2021
An Open-label, Non-Comparative Study to Evaluate the Steady-State Pharmacokinetics, Safety, and Efficacy of Mexiletine in Adolescents and Children With Myotonic Disorders
View All Clinical Trials